oral recombinant methioninase

Open Access
Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
YUTARO KUBOTA, QINGHONG HAN, SEI MORINAGA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

In Vivo September 2023, 37 (5) 2134-2138; DOI: https://doi.org/10.21873/invivo.13310
You have access
Efficacy of Oral Recombinant Methioninase and Eribulin on a PDOX Model of Triple-negative Breast Cancer (TNBC) Liver Metastasis
HYE IN LIM, YU SUN, QINGHONG HAN, JUN YAMAMOTO and ROBERT M. HOFFMAN

In Vivo September 2021, 35 (5) 2531-2534; DOI: https://doi.org/10.21873/invivo.12534
You have access
Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model
HYE IN LIM, JUN YAMAMOTO, QINHONG HAN, YU SUN, HIROTO NISHINO, YOSHIHIKO TASHIRO, NORIHIKO SUGISAWA, YUYING TAN, HEE JUN CHOI, SEOK JIN NAM, MICHAEL BOUVET and ROBERT M. HOFFMAN

In Vivo November 2020, 34 (6) 3163-3169; DOI: https://doi.org/10.21873/invivo.12151

Main menu